M.D. and Ph.D. in Medicine and Surgery from the Universidad Autónoma de Barcelona, Spain.  He trained in Neuro-oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and afterwards was appointed to the faculty. After 11 years at MSKCC, Dr. Dalmau took a position as co-director of Neuro-oncology at the University of Arkansas for Medical Sciences. In 2002 he moved to the Department of Neurology and Abramson Cancer Center of the University of Pennsylvania as Professor of Neurology. He is currently Research Professor at the Catalan Institution for Research and Advanced Studies (ICREA) in IDIBAPS/Hospital Clinic, University of Barcelona, and Adjunct Professor of Neurology at the University of Pennsylvania. His research is focused on autoimmune and paraneoplastic neurological disorders and his recent work has revealed a new category of disorders mediated by antibodies to neuronal cell surface and CNS synaptic proteins. Dr. Dalmau is a member of the National Academy of Medicine (USA) among others, associate editor of Neurology, and Editor of Neurology: Neuroimmunology and Neuroinflammation.